PT  - JOURNAL ARTICLE
AU  - Erik Lubberts
AU  - Jose U. Scher
AU  - Oliver FitzGerald
TI  - Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis
AID  - 10.3899/jrheum.211321
DP  - 2022 Jun 01
TA  - The Journal of Rheumatology
PG  - 16--19
VI  - 49
IP  - 6 Suppl 1
4099  - http://www.jrheum.org/content/49/6_Suppl_1/16.short
4100  - http://www.jrheum.org/content/49/6_Suppl_1/16.full
SO  - J Rheumatol2022 Jun 01; 49
AB  - The second basic science session at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) annual meeting focused on 2 recent publications that have increased our understanding of the pathogenesis of psoriatic arthritis (PsA). Data from the first publication, presented by Prof. Erik Lubberts, showed that interleukin (IL)-17A is produced by CD4+ and not CD8+ T cells in PsA synovial fluid following T cell receptor activation. These findings contrast with previously published data, which had suggested that CD8+ T cells are a prominent source of IL-17A. In further experiments, they showed that when CD8+ T cells were stimulated with paramethoxyamphetamine/ionomycin, relatively high levels of IL-17A were detected. Prof. Jose Scher presented work on the role of the microbiome in PsA and more specifically, on pharmacomicrobiomics. He demonstrated the baseline collection of genomes and genes from the microbiota community (the metagenome) can be used as predictor for future treatment response in early rheumatoid arthritis and also likely in PsA.